KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Capital Expenditures (2016 - 2026)

NovoCure's Capital Expenditures history spans 13 years, with the latest figure at $5.2 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 51.45% to $5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $21.2 million, a 49.17% decrease, with the full-year FY2025 number at $26.6 million, down 37.82% from a year prior.
  • Capital Expenditures hit $5.2 million in Q1 2026 for NovoCure, up from $4.9 million in the prior quarter.
  • Over the last five years, Capital Expenditures for NVCR hit a ceiling of $11.8 million in Q1 2024 and a floor of $4.1 million in Q2 2022.
  • Historically, Capital Expenditures has averaged $7.2 million across 5 years, with a median of $6.4 million in 2022.
  • Biggest five-year swings in Capital Expenditures: plummeted 54.95% in 2022 and later soared 93.56% in 2024.
  • Tracing NVCR's Capital Expenditures over 5 years: stood at $6.4 million in 2022, then increased by 6.06% to $6.8 million in 2023, then skyrocketed by 31.1% to $8.9 million in 2024, then tumbled by 45.25% to $4.9 million in 2025, then rose by 5.23% to $5.2 million in 2026.
  • Business Quant data shows Capital Expenditures for NVCR at $5.2 million in Q1 2026, $4.9 million in Q4 2025, and $5.7 million in Q3 2025.